Sacubitril/valsartan in heart failure: Differing added benefit

Posted by on June 20, 2016 3:20 pm
Categories: health

Due to a subgroup effect, reviewers have found that there is an indication of a minor added benefit for patients with diabetes, and an indication of a considerable added benefit for patients without diabetes, when using Sacubitril/valsartan in heart failure.

Leave a Reply

Your email address will not be published. Required fields are marked *